Cancer Research Versailles No Abst  Advances in Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 66, 11455, December 1, 2006. doi: 10.1158/0008-5472.CAN-06-2379
© 2006 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lyons, G. E.
Right arrow Articles by Nishimura, M. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lyons, G. E.
Right arrow Articles by Nishimura, M. I.

Immunology

Influence of Human CD8 on Antigen Recognition by T-Cell Receptor–Transduced Cells

Gretchen E. Lyons, Tamson Moore, Natasha Brasic, Mingli Li, Jeffrey J. Roszkowski and Michael I. Nishimura

Department of Surgery, The University of Chicago, Chicago, Illinois

Requests for reprints: Michael I. Nishimura, Department of Surgery, Medical University of South Carolina, Hollings Cancer Center, 86 Jonathon Lucas Street, Suite 512, P.O. Box 250613, Charleston, SC 29425. Phone: 843-792-7789; Fax: 843-792-2556; E-mail: nishimum{at}musc.edu.

The CD8 coreceptor on T cells has two functions. Namely, CD8 acts to stabilize the binding of the T-cell receptor (TCR) to the peptide-MHC complex while localizing p56lck (lck) to the TCR/CD3 complex to facilitate early signaling events. Although both functions may be critical for efficient activation of a CTL, little is known about how the structural versus signaling roles of CD8, together with the relative strength of the TCR, influences T-cell function. We have addressed these issues by introducing full-length and truncated versions of the CD8{alpha} and CD8ß chains into CD8 Jurkat cell clones expressing cloned TCRs with known antigen specificity and relative affinities. Using a combination of antigen recognition and tetramer-binding assays, we find that the intracellular lck-binding domain of CD8 is critical for enhanced T-cell activation regardless of the relative strength of the TCR. In contrast, the extracellular domain of CD8 seems to be critical for TCRs with lower affinity but not those with higher affinity. Based on our results, we conclude that there are different requirements for CD8 to enhance T-cell function depending on the strength of its TCR. (Cancer Res 2006; 66(23): 11455-61)




This article has been cited by other articles:


Home page
J. Immunol.Home page
J. Huang, L. J. Edwards, B. D. Evavold, and C. Zhu
Kinetics of MHC-CD8 Interaction at the T Cell Membrane
J. Immunol., December 1, 2007; 179(11): 7653 - 7662.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Laugel, H. A. van den Berg, E. Gostick, D. K. Cole, L. Wooldridge, J. Boulter, A. Milicic, D. A. Price, and A. K. Sewell
Different T Cell Receptor Affinity Thresholds and CD8 Coreceptor Dependence Govern Cytotoxic T Lymphocyte Activation and Tetramer Binding Properties
J. Biol. Chem., August 17, 2007; 282(33): 23799 - 23810.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.